Precision BioSciences Statistics
Share Statistics
Precision BioSciences has 10.48M
shares outstanding. The number of shares has increased by 51.35%
in one year.
| Shares Outstanding | 10.48M |
| Shares Change (YoY) | 51.35% |
| Shares Change (QoQ) | 36.64% |
| Owned by Institutions (%) | 56.45% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,996 |
| FTD / Avg. Volume | 1.27% |
Short Selling Information
The latest short interest is 652.19K, so 6.18% of the outstanding
shares have been sold short.
| Short Interest | 652.19K |
| Short % of Shares Out | 6.18% |
| Short % of Float | 6.39% |
| Short Ratio (days to cover) | 2.39 |
Valuation Ratios
The PE ratio is 3.63 and the forward
PE ratio is -1.06.
Precision BioSciences's PEG ratio is
-0.03.
| PE Ratio | 3.63 |
| Forward PE | -1.06 |
| PS Ratio | 0.38 |
| Forward PS | 0.7 |
| PB Ratio | 0.46 |
| P/FCF Ratio | -0.44 |
| PEG Ratio | -0.03 |
Financial Ratio HistoryEnterprise Valuation
Precision BioSciences has an Enterprise Value (EV) of -29.82M.
| EV / Sales | -0.43 |
| EV / EBITDA | -2.2 |
| EV / EBIT | 0.51 |
| EV / FCF | 0.51 |
Financial Position
The company has a current ratio of 6.34,
with a Debt / Equity ratio of 0.53.
| Current Ratio | 6.34 |
| Quick Ratio | 6.34 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | -0.51 |
| Interest Coverage | -14.68 |
Financial Efficiency
Return on Equity is 12.71% and Return on Invested Capital is -21.32%.
| Return on Equity | 12.71% |
| Return on Assets | 5.25% |
| Return on Invested Capital | -21.32% |
| Revenue Per Employee | $636,074.07 |
| Profits Per Employee | $66,361.11 |
| Employee Count | 108 |
| Asset Turnover | 0.5 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -44.58% in the
last 52 weeks. The beta is 1.58, so Precision BioSciences's
price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | -44.58% |
| 50-Day Moving Average | 5.09 |
| 200-Day Moving Average | 6.99 |
| Relative Strength Index (RSI) | 60.83 |
| Average Volume (20 Days) | 156,932 |
Income Statement
In the last 12 months, Precision BioSciences had revenue of 68.7M
and earned 7.17M
in profits. Earnings per share was 1.05.
| Revenue | 68.7M |
| Gross Profit | 64.12M |
| Operating Income | -26.16M |
| Net Income | 7.17M |
| EBITDA | 13.53M |
| EBIT | 8.95M |
| Earnings Per Share (EPS) | 1.05 |
Full Income StatementBalance Sheet
The company has 85.9M in cash and 30.05M in
debt, giving a net cash position of 55.85M.
| Cash & Cash Equivalents | 85.9M |
| Total Debt | 30.05M |
| Net Cash | 55.85M |
| Retained Earnings | -482.46M |
| Total Assets | 136.39M |
| Working Capital | 80.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -58.45M
and capital expenditures -250K, giving a free cash flow of -58.7M.
| Operating Cash Flow | -58.45M |
| Capital Expenditures | -250K |
| Free Cash Flow | -58.7M |
| FCF Per Share | -8.59 |
Full Cash Flow StatementMargins
Gross margin is 93.34%, with operating and profit margins of -38.08% and 10.43%.
| Gross Margin | 93.34% |
| Operating Margin | -38.08% |
| Pretax Margin | 10.43% |
| Profit Margin | 10.43% |
| EBITDA Margin | 19.69% |
| EBIT Margin | -38.08% |
| FCF Margin | -85.44% |
